Literature DB >> 2606216

Limbal vernal keratoconjunctivitis: clinical characteristics and immunoglobulin E expression compared with palpebral vernal.

S J Tuft1, J K Dart, M Kemeny.   

Abstract

Limbal and palpebral vernal keratoconjunctivitis (VKC) are usually considered to be different expressions of the same disease. This single centre population of 120 patients with VKC had 32 patients with limbal VKC, 54 with palpebral VKC and 34 with mixed palpebral and limbal VKC. There were higher proportions of females (p = 0.015) blacks, Indians and Asians (p = 0.0001) in the limbal group and fewer limbal patients had other atopic diseases (p = 0.03). The age of presentation was similar for all groups; 87/112 (78 per cent) presenting before the age of 16. The follow-up period was shorter in the limbal VKC patients (p = 0.004) suggesting a shorter disease course. Only one limbal VKC patient developed corneal opacities compared to fifty (47 per cent) with palpebral or mixed VKC, 24 (27 per cent) of whom lost vision. Tear and serum levels of total IgE and specific IgE to the major inhalent allergens cat, house dust mite and grass pollen were compared in 17 patients with palpebral or mixed VKC and ten with limbal VKC; no statistically significant differences were shown. However the significant variations in sex, racial distribution and associated atopic disease suggest that limbal VKC may be a different disease from palpebral VKC although this is not expressed in terms of IgE production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606216     DOI: 10.1038/eye.1989.63

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Vernal keratoconjunctivitis in school children in Rwanda and its association with socio-economic status: a population-based survey.

Authors:  Stefan De Smedt; John Nkurikiye; Yannick Fonteyne; Arjan Hogewoning; Marjan Van Esbroeck; Dirk De Bacquer; Stephen Tuft; Clare Gilbert; Joris Delanghe; Philippe Kestelyn
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

2.  The clinical picture of vernal kerato-conjunctivitis in Uganda.

Authors:  M Kawuma
Journal:  Community Eye Health       Date:  2001

Review 3.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

Review 4.  The role of the T follicular helper cells in allergic disease.

Authors:  D M Kemeny
Journal:  Cell Mol Immunol       Date:  2012-08-20       Impact factor: 11.530

5.  Eosinophil cationic protein in tears in allergic conjunctivitis.

Authors:  P G Montan; M van Hage-Hamsten
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

Review 6.  An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.

Authors:  Susanna Esposito; Giulia Fior; Alessandro Mori; Silvia Osnaghi; Daniele Ghiglioni
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.022

7.  Prevalence of vernal keratoconjunctivitis and its associated factors among children in Gambella town, southwest Ethiopia, June 2018.

Authors:  Abiy Maru Alemayehu; Betelhem Temesgen Yibekal; Sofonias Addis Fekadu
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

8.  To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital.

Authors:  Vadlakonda Sruthi; Resu Neha Reddy; K Sowmini; Nagur Sharone Grace
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.